|Articles|March 2, 2017
OmniComm, Bio-Optronics to Provide Solutions for Children's Cancer Center
Omnicomm Systems and Bio-Optronics have reached an agreement to integrate OmniComm’s TrialMaster EDC with Bio-Optronics CTMS solution for multiple facilities at a children’s health institution.
Advertisement
Omnicomm Systems and Bio-Optronics have reached an agreement to integrate OmniComm’s TrialMaster EDC with Bio-Optronics CTMS solution for multiple facilities at a children’s health institution seeking to develop cures and treatments for cancer and other diseases.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
3
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
4
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
